ArrayExpress Uploader0humanBreastMCF7WTnoneBreastMCF7WTnoneBreastMCF7WTDanusertibBreastMCF7WTDanusertibBreastMDA-MB-468mutnoneBreastMDA-MB-468mutnoneBreastMDA-MB-468mutDanusertibBreastMDA-MB-468mutDanusertibcolonHCT-116WTnonecolonHCT-116WTnonecolonHCT-116WTDanusertibcolonHCT-116WTDanusertibcolonCOLO205mutnonecolonCOLO205mutnonecolonCOLO205mutDanusertibcolonCOLO205mutDanusertibOvaryA2780WTnoneOvaryA2780WTnoneOvaryA2780WTDanusertibOvaryA2780WTDanusertib3827arrayexpress_sid4Treatment with Aurora inhibitors has been shown to induce diverse biological responses in different tumor cell lines, in part depending...E-GEOD-24547/profile/8773/arrayexpressuploader420breastcarcinomacellcoloncolon carcinomaleftlineovaryDec.12, 2014Falsetranscriptional-pathway-signatures-for-the-auroraE-GEOD-24547_A-AFFY-44Transcriptional pathway signatures for the Aurora inhibitor DanusertibSep.15, 2014Treatment with Aurora inhibitors has been shown to induce diverse biological responses in different tumor cell lines, in part depending on their p53 status. To characterize at the transcriptional level the effects of Danusertib we analyzed by microarray different tumor cell lines, with WT or mutant p53 status, that showed differential cell cycle response upon drug treatment. We analyzed the effects of Danusertib treatment in different tumor cell lines derived from ovary (A2780, p53WT), breast (MCF-7, p53WT and MDA-MB-468, p53 mut) and colon carcinoma (HCT116, p53 WT and Colo205, p53 mut). Cell line were treated (TRT) or left unreated (CTRL) for 24 hrs with 1 uM Danusertib.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-24547http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-24547/samples/